196 related articles for article (PubMed ID: 20421337)
21. Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical Trial.
Ejlsmark-Svensson H; Rolighed L; Rejnmark L
J Clin Endocrinol Metab; 2019 Aug; 104(8):3223-3232. PubMed ID: 30860588
[TBL] [Abstract][Full Text] [Related]
22. Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk.
Lewiecki EM; Miller PD
J Clin Densitom; 2013; 16(1):28-32. PubMed ID: 23374738
[TBL] [Abstract][Full Text] [Related]
23. Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidism.
Lowell AJ; Bushman NM; Wang X; Ma Y; Pitt SC; Sippel RS; Schneider DF; Randle RW
J Surg Res; 2017 Sep; 217():252-257. PubMed ID: 28711370
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of subclinical coronary atherosclerosis in mild asymptomatic primary hyperparathyroidism patients.
Kepez A; Harmanci A; Hazirolan T; Isildak M; Kocabas U; Ates A; Ciftci O; Tokgozoglu L; Gürlek A
Int J Cardiovasc Imaging; 2009 Feb; 25(2):187-93. PubMed ID: 18784985
[TBL] [Abstract][Full Text] [Related]
25. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.
Farahnak P; Lärfars G; Sten-Linder M; Nilsson IL
J Clin Endocrinol Metab; 2011 Jul; 96(7):2112-8. PubMed ID: 21593116
[TBL] [Abstract][Full Text] [Related]
26. Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone.
Maruani G; Hertig A; Paillard M; Houillier P
J Clin Endocrinol Metab; 2003 Oct; 88(10):4641-8. PubMed ID: 14557434
[TBL] [Abstract][Full Text] [Related]
27. Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism.
Schillaci G; Pucci G; Pirro M; Monacelli M; Scarponi AM; Manfredelli MR; Rondelli F; Avenia N; Mannarino E
Atherosclerosis; 2011 Sep; 218(1):96-101. PubMed ID: 21645899
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms.
Procopio M; Barale M; Bertaina S; Sigrist S; Mazzetti R; Loiacono M; Mengozzi G; Ghigo E; Maccario M
Endocrine; 2014 Nov; 47(2):581-9. PubMed ID: 24287796
[TBL] [Abstract][Full Text] [Related]
29. Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy.
Osto E; Fallo F; Pelizzo MR; Maddalozzo A; Sorgato N; Corbetti F; Montisci R; Famoso G; Bellu R; Lüscher TF; Iliceto S; Tona F
Circulation; 2012 Aug; 126(9):1031-9. PubMed ID: 22821942
[TBL] [Abstract][Full Text] [Related]
30. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
[TBL] [Abstract][Full Text] [Related]
31. Coexisting primary hyperparathyroidism and sarcoidosis cause increased angiotensin-converting enzyme and decreased parathyroid hormone and phosphate levels.
Lim V; Clarke BL
J Clin Endocrinol Metab; 2013 May; 98(5):1939-45. PubMed ID: 23493435
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis on the Effect of Mild Primary Hyperparathyroidism and Parathyroidectomy Upon Arterial Stiffness.
Bernardi S; Giudici F; Barbato V; Zanatta L; Grillo A; Fabris B
J Clin Endocrinol Metab; 2021 May; 106(6):1832-1843. PubMed ID: 33693666
[TBL] [Abstract][Full Text] [Related]
33. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism.
Bollerslev J; Rosen T; Mollerup CL; Nordenström J; Baranowski M; Franco C; Pernow Y; Isaksen GA; Godang K; Ueland T; Jansson S;
J Clin Endocrinol Metab; 2009 Jul; 94(7):2255-61. PubMed ID: 19351725
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
35. A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism.
Gianotti L; Tassone F; Cesario F; Pia A; Razzore P; Magro G; Piovesan A; Borretta G
J Clin Endocrinol Metab; 2006 Aug; 91(8):3011-6. PubMed ID: 16735490
[TBL] [Abstract][Full Text] [Related]
36. [Primary hyperparathyroidism].
Carnevale V; Romagnoli E; Pipino M; Scillitani A; D'Erasmo E; Minisola S; Mazzuoli G
Clin Ter; 2005; 156(5):211-26. PubMed ID: 16382970
[TBL] [Abstract][Full Text] [Related]
37. Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
Cong X; Shen L; Gu X
Urolithiasis; 2018 Oct; 46(5):453-457. PubMed ID: 29350243
[TBL] [Abstract][Full Text] [Related]
38. [Nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: focus on calciomimetics].
Brardi S; Ponchietti R; Duranti E
G Ital Nefrol; 2016; 33(6):. PubMed ID: 28134399
[TBL] [Abstract][Full Text] [Related]
39. Retinal micro-vascular and aortic macro-vascular changes in postmenopausal women with primary hyperparathyroidism.
Pepe J; Cipriani C; Tedeschi M; Curione M; Parravano M; Varano M; Biamonte F; Colangelo L; Minisola S
Sci Rep; 2018 Nov; 8(1):16521. PubMed ID: 30410012
[TBL] [Abstract][Full Text] [Related]
40. Pulse wave velocity in familial combined hyperlipidemia.
ter Avest E; Holewijn S; Bredie SJ; van Tits LJ; Stalenhoef AF; de Graaf J
Am J Hypertens; 2007 Mar; 20(3):263-9. PubMed ID: 17324737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
